EUVIMEDEUVIMED entdecken
Leserbrief

Re: “Noncoding RNAs Interplay in Ovarian Cancer Therapy and Drug Resistance” by Liu et al.

Belma Gözde Özdemir iD

Cancer Biotherapy and Radiopharmaceuticals · 2024

DOI: 10.1089/cbr.2023.0167 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Cancer Biotherapy and Radiopharmaceuticals, 2024. Verfasst von Belma Gözde Özdemir. Beteiligte Einrichtung: Selcuk University, Faculty of Medicine, Department of Obstetrics and Gynecology, Konya, Turkey. Hauptthemen laut MEDLINE: Ovarian Neoplasms, RNA, Long Noncoding, MicroRNAs. Die Arbeit nennt 4 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ovarian NeoplasmsRNA, Long NoncodingMicroRNAsHumansFemaleRNA, UntranslatedDrug Resistance

Substanzen

RNA, UntranslatedRNA, Long NoncodingMicroRNAs

Autor:innen und Institutionen

  • Selcuk University, Faculty of Medicine, Department of Obstetrics and Gynecology, Konya, Turkey.

ORCID-Profile: Belma Gözde Özdemir

Zitieren

APA

Özdemir, B. G. (2024). Re: “Noncoding RNAs Interplay in Ovarian Cancer Therapy and Drug Resistance” by Liu et al. Cancer Biotherapy and Radiopharmaceuticals. https://doi.org/10.1089/cbr.2023.0167

Vancouver

Özdemir BG. Re: “Noncoding RNAs Interplay in Ovarian Cancer Therapy and Drug Resistance” by Liu et al. Cancer Biotherapy and Radiopharmaceuticals. 2024. doi:10.1089/cbr.2023.0167

BibTeX
@article{zdemir2024,
  author = {Özdemir, Belma Gözde},
  title = {Re: “Noncoding RNAs Interplay in Ovarian Cancer Therapy and Drug Resistance” by Liu et al},
  journal = {Cancer Biotherapy and Radiopharmaceuticals},
  year = {2024},
  doi = {10.1089/cbr.2023.0167}
}
Kostenlos starten →